Detalhe da pesquisa
1.
Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine dose.
Nat Immunol
; 23(6): 940-946, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35534723
2.
SARS-CoV-2 IgG Levels as Predictors of XBB Variant Neutralization, Israel, 2022- and 2023.
Emerg Infect Dis
; 30(5): 1050-1052, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38666742
3.
Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months.
N Engl J Med
; 385(24): e84, 2021 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34614326
4.
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.
N Engl J Med
; 385(16): 1474-1484, 2021 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34320281
5.
Rapid molecular epidemiology investigations into two recent measles outbreaks in Israel detected from October 2023 to January 2024.
Euro Surveill
; 29(16)2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38639095
6.
The Association Between Prebooster Vaccination Antibody Levels and the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Clin Infect Dis
; 76(7): 1315-1317, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36366729
7.
Cellular and humoral response to the fourth BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL.
Eur J Haematol
; 110(1): 99-108, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36208015
8.
Early Immunogenicity and Safety of the Third Dose of BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Among Adults Older Than 60 Years: Real-World Experience.
J Infect Dis
; 225(5): 785-792, 2022 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34850049
9.
Existence of immunological memory response in true sero-negative individuals post COVID-19 molecular diagnosis.
Clin Infect Dis
; 2022 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35271690
10.
A third dose of the BNT162b2 mRNA vaccine significantly improves immune responses among liver transplant recipients.
J Hepatol
; 77(3): 702-709, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35452692
11.
Immunogenicity and Adverse Effects of the 2-Dose BNT162b2 Messenger RNA Vaccine Among Liver Transplantation Recipients.
Liver Transpl
; 28(2): 215-223, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34767690
12.
A case report of human infection with lymphocytic choriomeningitis virus in Israel.
J Med Virol
; 94(8): 4012-4014, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35352372
13.
Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia.
Haematologica
; 107(3): 625-634, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34320789
14.
BNT162b2 Third Booster Dose Significantly Increases the Humoral Response Assessed by Both RBD IgG and Neutralizing Antibodies in Renal Transplant Recipients.
Transpl Int
; 35: 10239, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35387393
15.
Comparing immunogenicity and efficacy of two different mRNA-based COVID-19 vaccines as a fourth dose; six-month follow-up, Israel, 27 December 2021 to 24 July 2022.
Euro Surveill
; 27(39)2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36177870
16.
Potential Antigenic Cross-reactivity Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Dengue Viruses.
Clin Infect Dis
; 73(7): e2444-e2449, 2021 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32797228
17.
The role of mouthwash sampling in SARS-CoV-2 diagnosis.
Eur J Clin Microbiol Infect Dis
; 40(10): 2199-2206, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34342767
18.
SARS-CoV-2 outbreak in a synagogue community: longevity and strength of anti-SARS-CoV-2 IgG responses.
Epidemiol Infect
; 149: e153, 2021 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34372950
19.
Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel.
Eur J Epidemiol
; 36(7): 727-734, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33884542
20.
Under-diagnosis of SARS-CoV-2 infections among children aged 0-15 years, a nationwide seroprevalence study, Israel, January 2020 to March 2021.
Euro Surveill
; 26(48)2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34857069